Teva Pharma, Zoetis, Orexigen Therapeutics, Novartis, and Actavis Early Briefing and Review

   Teva Pharma, Zoetis, Orexigen Therapeutics, Novartis, and Actavis Early
                             Briefing and Review

PR Newswire

LONDON, March 5, 2013

LONDON, March 5, 2013 /PRNewswire/ --

The Healthcare sector showed a healthy trend as the markets continued their
upward ascent. Major drug manufacturing remained range-bound with positive
bias as the sector prepares to deal with healthcare regulations. On Monday,
The Dow Jones ended its latest session at 14,127.82, up 0.27 percent while
NASDAQ was up 0.39 percent to close at 3,182.03. Similarly, S&P also ended at
a positive note at 1,525.20, up 0.46 percent. Our research team took a look at
Healthcare sector, notably the Drug Manufacturers industry which includes
major companies like Teva Pharmaceutical Industries Ltd (NYSE:TEVA), Zoetis
Inc. (NYSE: ZTS), Orexigen Therapeutics Inc. (NASDAQ: OREX), Novartis AG
(NYSE: NVS) and Actavis Inc. (NYSE: ACT). StockCall has released free charting
and technical research on these aforementioned companies. Register to read
these reports at 

Teva Pharmaceutical Industries Ltd traded in the range of $37.03 and $37.44 in
its latest trading session and ended the day flat at $37.25. The stock's 52
weeks range stands at $36.63 and $46.38. Teva has lost 17.68 percent of its
value in the past 12 months, while it lost 0.24 percent so far this year so
far. Teva Pharmaceutical Industries Ltd is in a neutral mode and may find its
first support level at $37.11. It is trading below its 20-day moving average
of $38.05. Sign up for the free report on TEVA at 

Shares of Zoetis Inc. ended Monday's trading session marginally down at
$34.35, 0.72 percent. The stock gained more than 10 percent this year,
outperforming the broad market. It has support at around $33.54 at the moment.
Despite its downward movement, the company is still trading above its 50-day
moving average price of $33.64. The stock traded 865,000 shares during the
session. ZTS free technical report can be accessed by signing up at 

Orexigen Therapeutics stock is in a bullish mode and is trading above its
20-day SMA of 6.44. It ended its latest trading session 7.28 percent higher at
$6.48, and the stock oscillated in the range of $5.92 and $6.49 during
Monday's session. The stock trades at beta of 1.94. Orexigen is expected to
face its first resistance level at $6.63. Free report on OREX can be accessed
by registering at 

Novartis AG stock closed at $68.90, 1.10 percent up. The stock traded in the
range of $68.33 and $68.91 during the session and is currently above it 20-day
moving average price of $68.83. The drug maker gained 8.85 percent so far this
year. Its Price/Earnings ratio is 17.71. Novartis stock is in a bullish phase
and its first resistance level is at $70.14. On the downside, its first
support is at $67.87. Upon breaching this level, its second support level is
at $66.58. Register with StockCall and download the research on NVS for free

With a mild upward movement in yesterday's trading session, Actavis Inc. is up
0.23 percent for the year. It has gained 44.44 percent in the past 52 weeks.
The stock closed 0.77 percent higher at $86.20 on volume of 817,000 shares.
Its average trading volume stands at 1.27 million shares. The company's shares
currently face resistance at around $87.88. The stock has support at around
$83.90. It is currently trading above its 20-day and 50-day moving averages,
which is a bullish signal. Read the full free research on ACT by signing up to
StockCall at 

About is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at 


Contact: Contact Person:William T. Knight, Email:, Contact
Number: +1(646) 396-9857 (9:00 am EST - 01:30 pm EST)
Press spacebar to pause and continue. Press esc to stop.